Fig. 4.
Graphical representation of the influence of beta-2 adrenergic receptor agonists on loss of skeletal and cardiac muscle during cancer cachexia. Stimulation of beta-2 adrenergic receptor on both skeletal and cardiac muscle leads to increased protein synthesis and decreased protein degradation, which attenuates loss of lean mass in patients with cancer cachexia.